Search

Your search keyword '"Andreone, Pietro"' showing total 471 results

Search Constraints

Start Over You searched for: Author "Andreone, Pietro" Remove constraint Author: "Andreone, Pietro" Search Limiters Full Text Remove constraint Search Limiters: Full Text
471 results on '"Andreone, Pietro"'

Search Results

1. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.

2. Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis

3. Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

4. A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

5. Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study

7. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

8. Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments.

9. Frailty after Liver Transplantation: A Complex Unexplored Issue.

11. OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY

13. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

15. miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals.

16. Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

18. Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series

20. Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells

22. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?

24. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients

25. Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter study

28. Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

32. Elastography Point Quantification in the evaluation of liver fibrosis in NAFLD patients

33. Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]

35. Efficacy and Safety of 144 Weeks of Bulevirtide 2 mg or 10 mg Monotherapy from the Ongoing Phase 3 Study MYR301.

38. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

42. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

43. Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC)

45. Mo1537 EFFICACY AND SAFETY OF BULEVIRTIDE MONOTHERAPY GIVEN AT 2 MG OR 10 MG DOSE LEVEL ONCE DAILY FOR TREATMENT OF CHRONIC HEPATITIS DELTA: WEEK 48 PRIMARY ENDPOINT RESULTS FROM A PHASE 3 RANDOMIZED, MULTICENTER, PARALLEL-DESIGN STUDY

47. Validation and refinement of PROSASH model using the neutrophil‐to‐lymphocyte ratio in patients with HCC receiving sorafenib

Catalog

Books, media, physical & digital resources